Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection.

•We examined the cost-effectiveness of four pertussis vaccination programmes.•We calculated the incremental cost-effectiveness ratio and benefit-cost ratio.•None of the four programmes was cost-effective at an incidence of 25 per 100,000.•If intergenerational infection considered, one-time adolescent DTaP was cost-effective.